Panagora Asset Management’s Tetraphase Pharmaceuticals, Inc. TTPH Stock Holding History

Panagora Asset Management’s Portfolio TTPH Stock Details TTPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-138	Closed	-$8K	–	2578
2018 Q3	$8K	Sell	138 -36,355	-100%	-$2.32M	﹤0.01%	2325
2018 Q2	$2.61M	Buy	36,493 +8,548	+31%	+$604K	0.01%	776
2018 Q1	$1.72M	Buy	27,945 +18,452	+194%	+$1.62M	0.01%	930
2017 Q4	$1.2M	Buy	9,493 +6,356	+203%	+$814K	﹤0.01%	1068
2017 Q3	$429K	Hold	3,137	–	–	﹤0.01%	1407
2017 Q2	$447K	Buy	+3,137	New	+$485K	﹤0.01%	1383
2016 Q2	–	Sell	-6,397	Closed	-$592K	–	2375
2016 Q1	$592K	Buy	6,397 +6,066	+1,833%	+$606K	﹤0.01%	1296
2015 Q4	$66K	Buy	331 +242	+272%	+$48.3K	﹤0.01%	1904
2015 Q3	$13K	Buy	89 +3	+3%	+$2.2K	﹤0.01%	2200
2015 Q2	$81K	Buy	+86	New	+$70.3K	﹤0.01%	2013
2015 Q1	–	Sell	-365	Closed	-$290K	–	2406
2014 Q4	$290K	Buy	+365	New	+$196K	﹤0.01%	1488
2013 Q3	–	Sell	-1,039	Closed	-$146K	–	2392
2013 Q2	$146K	Buy	+1,039	New	+$165K	﹤0.01%	1753

Other funds holding TTPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

TCM

Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Panagora Asset Management's TTPH Position: Q4 2018 in Review

Panagora Asset Management sold out of Tetraphase Pharmaceuticals, Inc. (TTPH) in Q4 2018, closing a stake of 138 shares — an estimated $8K sold.

Panagora Asset Management first reported a position in TTPH in Q2 2013 and held it in 12 quarters. The position peaked at $2.61M in Q2 2018. 86 funds tracked by Wall St. Rank hold TTPH as of Q4 2018.

Panagora Asset Management reported no remaining Tetraphase Pharmaceuticals, Inc. position as of Q4 2018 after selling out during the quarter.
Panagora Asset Management sold 138 Tetraphase Pharmaceuticals, Inc. shares in Q4 2018, an estimated $8K.
Panagora Asset Management first reported a position in Tetraphase Pharmaceuticals, Inc. in Q2 2013 and held it in 12 quarters.
Panagora Asset Management's Tetraphase Pharmaceuticals, Inc. position peaked at $2.61M in Q2 2018.
86 funds tracked by Wall St. Rank held Tetraphase Pharmaceuticals, Inc. as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.